Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Testing Trump: Advocates urge action over pricey cancer drug

  • Ed Silverman

By Ed Silverman April 19, 2017

Reprints
Astellas
Kristoffer Tripplaar/Sipa USA/AP

If at first you don’t succeed …

After being rebuffed by the Obama administration, a consumer advocacy group is now asking the Trump administration to use federal law to widen access in the United States to a pricey prostate cancer drug that was developed with taxpayer funds.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed Silverman covers the pharmaceutical industry.

Tags

Researching collagen to help his achy knees, a statistician…
Researching collagen to help his achy knees, a statistician explores the painfully weak evidence
Human reproductive cloning: The curious incident of the dog…
Human reproductive cloning: The curious incident of the dog in the night-time
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
California judge deals GSK a setback as first Zantac…
California judge deals GSK a setback as first Zantac lawsuit will now go to trial
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: EU delays pharma legislation again; India cancels license…
Pharmalittle: EU delays pharma legislation again; India cancels license for maker of cough syrup linked to…

Recommended Stories